Oligohydramnios, often shortened to “oligo” in prenatal care, means there is less amniotic fluid around the baby than expected. It affects a variable percentage of pregnancies depending on how it is measured, and the consequences range from clinically insignificant to severe, depending largely on the cause and the stage of pregnancy when it appears. A diagnosis of oligo can feel alarming, but understanding what drives it, how it is detected, and what it actually means for your pregnancy makes a real difference in how you navigate the weeks that follow.
What Amniotic Fluid Does and Where It Comes From
Amniotic fluid is not just sitting there passively. It cushions the baby, allows movement that helps muscles and joints develop, and plays a critical role in lung maturation because the baby “breathes” it in and out. By mid-pregnancy, most of the fluid is produced by the baby’s own kidneys and urinary output. A second major source is fluid secreted by the fetal lungs. On the absorption side, the baby swallows amniotic fluid constantly, which is one of the main ways volume is regulated. When swallowing alone doesn’t balance production, a secondary pathway across the amniotic membrane into the fetal blood vessels helps maintain the right amount of fluid.1Placenta. Amniotic Fluid Water Dynamics Animal research has even identified that substances in fetal urine stimulate this membrane absorption, meaning the baby’s own kidneys play a double role: producing fluid and helping regulate how fast it gets reabsorbed.2PubMed Central. Regulation of intramembranous absorption and amniotic fluid volume by constituents in fetal sheep urine
This elaborate recycling system means that anything interfering with the baby’s kidney function, blood flow through the placenta, or the integrity of the membranes can shift the balance toward too little fluid. That is why oligo has such a wide range of causes and why figuring out the “why” matters more than the measurement itself.
How Oligohydramnios Is Measured and Why the Method Matters
Two ultrasound techniques dominate: the amniotic fluid index (AFI), which adds up the deepest pockets of fluid in four quadrants of the uterus, and the single deepest pocket (SDP) method, which measures just the deepest vertical pocket of fluid. A traditional cutoff for oligo using AFI is 5 cm or less, while the SDP threshold is typically 2 cm or less. These numbers sound straightforward, but which method your provider uses can dramatically change whether you receive the diagnosis at all.
A Cochrane review pooling data from four trials and over 3,000 women found that when the AFI method was used, oligo was diagnosed roughly twice as often compared with SDP. Women monitored by AFI were also about twice as likely to be induced and had a higher rate of cesarean delivery for fetal distress. Crucially, none of those extra interventions improved actual outcomes for babies: rates of neonatal intensive care admission, low Apgar scores, umbilical cord pH problems, and meconium were all similar between the two groups.3PubMed Central. Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome Individual trials confirm this pattern. One randomized trial found that AFI flagged 17% of patients as having oligo versus 10% using SDP, with no difference in cesarean rates for concerning heart tracings, cord pH, or NICU admissions between groups.4PubMed. Amniotic fluid index vs single deepest pocket technique during modified biophysical profile: a randomized clinical trial A larger multicenter trial (the SAFE trial) showed an even starker gap: oligo was diagnosed in about 10% of the AFI group versus just over 2% in the SDP group, and induction for oligo was more than three times as common in the AFI arm, again without any improvement in NICU admissions or other neonatal outcomes.5PubMed. Single deepest vertical pocket or amniotic fluid index as evaluation test for predicting adverse pregnancy outcome (SAFE trial)
The practical takeaway: the Cochrane authors concluded that SDP appears to be the better choice because AFI leads to more diagnoses and more interventions without better outcomes for babies. If you are told you have oligo, it is worth asking which measurement method was used and what your actual numbers are, because the label itself can be an artifact of the technique.
Common Causes of Low Amniotic Fluid
Oligo is not a single condition so much as a sign that something in the fluid-recycling system is off. The underlying cause shapes both the severity and the management. The most common categories break down roughly as follows:
- Placental insufficiency: When the placenta is not delivering enough blood, oxygen, and nutrients to the baby, the baby’s kidneys get less perfusion and produce less urine, which means less fluid. This is frequently linked with fetal growth restriction in the later weeks of pregnancy.6PubMed Central. Placental insufficiency and fetal growth restriction
- Fetal kidney or urinary tract problems: Because the baby’s urine is the main source of fluid after mid-pregnancy, anomalies like absent kidneys, obstructed ureters, or other urinary tract malformations can reduce or eliminate fluid production. These cases can lead to severe oligo or even no fluid at all, which in turn threatens lung development and can cause abnormal limb positioning.7PubMed. Fetal Urinary Tract Anomalies: Review of Pathophysiology, Imaging, and Management
- Ruptured membranes: If the amniotic sac leaks, fluid can drain faster than it is replaced. Preterm premature rupture of membranes (PPROM) is a well-recognized cause of oligo, and it brings its own set of risks including infection.8PubMed Central. Perinatal outcome in preterm premature rupture of membranes with Amniotic fluid index < 5 (AFI < 5)
- Medications: Certain blood-pressure drugs, particularly ACE inhibitors, are strongly linked to oligo when used after the first trimester. They interfere with fetal kidney function, reducing urine output. The resulting pattern of complications can include lung underdevelopment, skull malformations, and limb contractures.9PubMed. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment NSAIDs (like ibuprofen) taken in later pregnancy can also reduce fetal urine output, though this is more commonly a concern in the third trimester.
- Post-term pregnancy: After 41 to 42 weeks, amniotic fluid tends to decline naturally. In post-term pregnancies, the rate of oligo increases, and values dropping below an AFI of 5 have been associated with fetal heart rate problems and meconium.10American Journal of Obstetrics and Gynecology. Longitudinal measurement of amniotic fluid index in postterm pregnancies and its association with fetal outcome
- Idiopathic (no identifiable cause): In a substantial number of cases at or near term, fluid is low and no underlying cause can be found. This “isolated” oligo has been the subject of considerable debate about whether it truly requires early delivery.
When It Appears Changes Everything
The gestational age at which oligo is discovered is one of the strongest predictors of outcome. A study of singleton pregnancies with severe oligo found that when diagnosed in the second trimester, about half the cases involved fetal abnormalities, and only about 10% of those pregnancies resulted in surviving infants. When severe oligo appeared in the third trimester, fetal abnormalities were present in roughly a fifth of cases, and the survival rate jumped to about 85%.11PubMed. Outcome of singleton pregnancies with severe oligohydramnios in the second and third trimesters These two groups represent genuinely different populations in terms of what is going wrong and what outcomes to expect.
Early second-trimester oligo is often driven by structural problems like absent kidneys or severe urinary tract obstruction, or by very early membrane rupture. These scenarios give the baby less time to develop in an adequate fluid environment, and the consequences for lung and limb development are more serious. Third-trimester oligo, by contrast, is more often related to placental aging, mild insufficiency, or simply running past your due date. The baby’s lungs have already had most of their critical development time in fluid, and the prognosis is far better.
Risks to the Baby
The specific risks depend on severity and duration, but they cluster into a few key areas. Reduced fluid means less cushion around the umbilical cord, which makes cord compression during contractions more likely. This shows up on monitoring as variable decelerations in the baby’s heart rate, and it is the most common intrapartum concern with oligo.12Cochrane Database of Systematic Reviews. Maternal hydration for increasing amniotic fluid volume in oligohydramnios and normal amniotic fluid volume Meconium, if the baby passes stool in utero, is also more concentrated in low-volume fluid, which can be a problem if aspirated.
When oligo is severe and prolonged, particularly in the second trimester, the physical pressure of the uterine wall against the baby without sufficient fluid cushion can lead to limb contractures and a characteristic facial appearance sometimes called Potter sequence.13PubMed Central. Rare manifestations of Potter Sequence: A Case Report The most dangerous consequence of prolonged severe oligo is pulmonary hypoplasia, meaning the lungs do not develop enough to support breathing after birth. The baby needs to “breathe” amniotic fluid in and out for the lungs to expand and mature properly, so weeks without adequate fluid during the critical window can be devastating.
For babies whose oligo stems from kidney or urinary tract malformations, the kidney problems themselves persist after birth. A long-term follow-up of children who survived oligo caused by renal anomalies found that all 16 surviving children had chronic kidney disease, with half of them reaching end-stage kidney failure at a median age of just a few months. Most needed dialysis or transplantation, and growth was impaired in nearly half the group, though cognitive development was normal in three-quarters of the children.14Nephrology Dialysis Transplantation. Antenatal oligohydramnios of renal origin: long-term outcome These outcomes reflect the underlying kidney disease rather than the low fluid itself, but they underscore why identifying the cause of oligo matters so much for counseling families.
The Debate Over Isolated Oligo at Term
Here is where the clinical picture gets genuinely contentious. When a near-term or term pregnancy has low fluid but the baby is growing normally, there are no structural anomalies, membranes are intact, and no obvious cause is found, this is called “isolated oligohydramnios.” The question of whether these pregnancies need to be induced or can safely continue with monitoring has been debated for decades.
A systematic review and meta-analysis found that pregnancies with isolated oligo had significantly higher rates of both labor induction (roughly seven to eight times higher) and cesarean delivery (about twice as high) compared with pregnancies with normal fluid.15Fetal Diagnosis and Therapy. Isolated Oligohydramnios at Term as an Indication for Labor Induction: A Systematic Review and Meta-Analysis A separate study using SDP as the measurement confirmed more cesarean deliveries and more abnormal heart-rate tracings in pregnancies with isolated oligo.16PubMed Central. Perinatal Outcome in Pregnant Women With Isolated Oligohydramnios Diagnosed With the Single Deepest Pocket Method Yet a review of amniotic fluid dynamics pointed out that without prospective randomized data, it is unclear whether routinely delivering for isolated oligo at term actually improves outcomes.17PubMed. A review of amniotic fluid dynamics and the enigma of isolated oligohydramnios
The concern is circular: providers see low fluid, intervene with induction or cesarean, and then count the intervention itself as evidence that the condition is dangerous. Without a clear randomized trial comparing induction to watchful monitoring for isolated oligo at term, the evidence base for early delivery remains weaker than many assume. That said, many providers feel uncomfortable waiting because the potential downside of cord compression or placental insufficiency is serious, even if the probability is low. This is a conversation worth having with your care team, particularly about whether your measurement was made with AFI or SDP and whether any other risk factors are present.
Hydration as a Treatment
One of the simplest interventions for oligo is also one of the least dramatic: drinking more water. A Cochrane review found that maternal hydration was associated with a meaningful increase in amniotic fluid volume in women with oligo. Intravenous hydration with fluids less concentrated than blood (hypotonic fluids) also raised fluid volume.18PubMed Central. Maternal hydration for increasing amniotic fluid volume in oligohydramnios and normal amniotic fluid volume A meta-analysis looking at different strategies found that for isolated oligo specifically, oral hydration outperformed intravenous hydration, and hypotonic solutions (basically, plain water) worked better than isotonic solutions. The improvement appeared to be more related to how long you kept hydrating than to the total daily amount consumed.19PLOS ONE. An Update on Maternal Hydration Strategies for Amniotic Fluid Improvement in Isolated Oligohydramnios and Normohydramnios: Evidence from a Systematic Review of Literature and Meta-Analysis
A smaller trial comparing oral versus intravenous hydration in borderline oligo found that oral hydration raised the amniotic fluid index by about 45% by the time of delivery, compared with about 31% with IV fluids.20International Journal of Reproduction, Contraception, Obstetrics and Gynecology. Effect of oral and intravenous hydration therapy on amniotic fluid index, maternal and perinatal outcome in borderline oligohydramnios The honest caveat here is that while the numbers on the ultrasound improve, the evidence on whether hydration actually changes hard outcomes like NICU admissions or perinatal death is still fragmentary. Still, drinking plenty of water is low-risk and inexpensive, and many providers recommend it as a first step, especially for borderline cases.
Amnioinfusion During Labor
Amnioinfusion is a procedure where sterile saline is infused into the uterus through a catheter during labor. It is not a treatment for oligo per se, but rather a way to manage the intrapartum complications that oligo causes, particularly variable decelerations from cord compression. One trial showed that when amnioinfusion was used in laboring women with low fluid after membrane rupture, variable decelerations dropped from 91% to 74% and late decelerations dropped from 58% to 26%.21PubMed. Amnioinfusion in term labor with low amniotic fluid due to rupture of membranes: a new indication
The success of amnioinfusion appears to depend partly on how low the fluid was to begin with. A study of 85 patients found that when the initial AFI was 0 to 4 cm, amnioinfusion relieved variable decelerations about 76% of the time. As the starting fluid level increased, success rates actually dropped, suggesting the technique works best precisely in the situations where oligo is most pronounced and cord compression is the clearest mechanism.22PubMed. Amniotic fluid index predicts the relief of variable decelerations after amnioinfusion bolus Amnioinfusion is not universally available or universally used, and it requires ruptured membranes and internal monitoring, so it is a labor-room tool rather than an outpatient treatment.
ACE Inhibitors and Other Medication-Related Causes
The link between ACE inhibitors and oligo deserves special attention because it is one of the most clearly preventable causes. These medications, commonly prescribed for high blood pressure, include drugs like enalapril, lisinopril, and benazepril. When taken after the first trimester, they interfere with the developing fetal kidneys and can cause a characteristic pattern of complications: oligo, kidney failure in the newborn, skull ossification defects, lung underdevelopment, and limb contractures.23The American Journal of Medicine. Risks of angiotensin-converting enzyme inhibition during pregnancy: Experimental and clinical evidence, potential mechanisms, and recommendations for use In at least some cases, the oligo is reversible if the medication is stopped in time. A case report described a woman who developed severe oligo on benazepril at 27 weeks, with resolution after the drug was discontinued.24PubMed. Reversible oligohydramnios in a pregnancy with angiotensin-converting enzyme inhibitor exposure
If you are taking an ACE inhibitor or an angiotensin receptor blocker (ARB, a related class) and become pregnant or are planning pregnancy, switching to a safer blood-pressure medication is standard practice. This is one of the first things your provider should address, and it is a change that genuinely prevents harm.
How Oligo Is Monitored When Delivery Is Not Immediate
When oligo is diagnosed but the baby is too premature for delivery, or when the clinical picture suggests watchful waiting, monitoring becomes the primary management strategy. This typically involves regular ultrasound checks of fluid volume, fetal growth scans, and some form of fetal heart-rate surveillance such as non-stress tests or biophysical profiles.
The biophysical profile (BPP), which combines ultrasound assessment of fetal movement, breathing, muscle tone, and amniotic fluid with a non-stress test, is widely used in high-risk pregnancies. However, a Cochrane review of five trials involving nearly 3,000 women found no clear evidence that routine BPP testing improved perinatal survival or reduced low Apgar scores compared with standard monitoring. Two higher-quality trials within that review actually suggested a higher cesarean rate in the BPP group.25Cochrane Database of Systematic Reviews. Biophysical profile for fetal assessment in high risk pregnancies This does not mean monitoring is useless, but it does mean that more testing does not automatically translate to better outcomes, and the type and frequency of surveillance should be tailored to the specific clinical situation rather than applied reflexively.
For pregnancies complicated by PPROM and oligo, the picture shifts because the main additional risk is infection. One study found significantly more clinical chorioamnionitis in PPROM patients with very low fluid levels compared with those who maintained some volume.26PubMed Central. Perinatal outcome in preterm premature rupture of membranes with Amniotic fluid index < 5 (AFI < 5) Interestingly, a larger study from the NICHD network found that low fluid after PPROM was not associated with increased rates of amnionitis when women were treated with antibiotics.27PubMed. The NICHD-MFMU antibiotic treatment of preterm PROM study: impact of initial amniotic fluid volume on pregnancy outcome This discrepancy likely reflects the role of antibiotics in reducing infection risk, which is now standard care in PPROM management. Monitoring in these cases focuses heavily on signs of infection (maternal temperature, blood work, fetal heart rate patterns) alongside fluid-level tracking.
Borderline Cases and What “Low Normal” Means
Not every low measurement constitutes true oligo. Fluid levels fluctuate throughout the day and can change with hydration status, bladder fullness, fetal position, and even the ultrasound technician’s technique. A single borderline reading, say an AFI of 5 to 8 or an SDP just above 2 cm, often prompts a recheck rather than immediate action. Many providers will recommend increased water intake and repeat the scan in a few days.
The trouble with borderline readings is that they can create significant anxiety without necessarily reflecting any real problem. Fluid volume naturally decreases as pregnancies approach and pass 40 weeks, and a mildly low reading in an otherwise healthy pregnancy with a normally growing baby and reassuring heart-rate patterns may not represent a pathological state at all. The measurement technique itself has enough variability that the same pregnancy can read as “low normal” one day and “borderline oligo” the next depending on when and how the scan is done. If you find yourself in this gray zone, the most useful questions to ask your provider are whether the baby is growing well, whether any underlying cause has been identified, and whether the fluid trend over repeat measurements is stable or declining.